For citations:
Erdes Sh.F., Mazurov V.I., Gaydukova I.Z., Anoshenkova O.N., Vinogradova I.B., Grabovetskaya Yu.Yu., Davidian S.Yu., Epifanova O.E., Kiryukhina N.A., Masneva L.V., Menshikova I.V., Mironenko O.N., Nikulenkova N.E., Povarova T.V., Polyatika A.N., Samigullina R.R., Sizikov A.E., Totrov I.N., Umnova I.F., Chudinov A.L. Real-world retention rate, effectiveness, and safety of netakimab in the treatment of patients with ankylosing spondylitis: Two-year results of the real word evidence LIBRA study. Rheumatology Science and Practice. 2025;63(3):253-261. (In Russ.) https://doi.org/10.47360/1995-4484-2025-253-261
Email this article 